Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
Phase 3
Completed
- Conditions
- Alzheimer Disease
- Registration Number
- NCT00036114
- Brief Summary
The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Institutionalized patients with Alzheimer's
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of aripiprazole in treating Alzheimer's psychosis?
How does aripiprazole compare to standard antipsychotics in Alzheimer's dementia trials?
Which biomarkers correlate with aripiprazole response in Alzheimer's psychosis patients?
What adverse events are associated with aripiprazole in elderly Alzheimer's patients?
Are there combination therapies with aripiprazole for Alzheimer's-related behavioral symptoms?
Trial Locations
- Locations (1)
Local Institution
🇺🇸Seattle, Washington, United States
Local Institution🇺🇸Seattle, Washington, United States